Abstract-A procedure to optimize the specific absorption rate deposed in the patient during oncology hyperthermia treatment is presented. It is based on a genetic algorithm coupled to a finiteelement formulation. The optimization procedure is applied to a real human body obtained from computerized tomography scans.
I. INTRODUCTION

H
YPERTHERMIA is used in oncology treatment to treat localized cancerous tumors [1] . The aim of local hyperthermia therapy is to increase the tumor temperature to a range of 42 C-45 C, while keeping the temperatures in healthy tissues at acceptable levels. The temperature elevation of the tumoral volume increase the effectiveness of conventional treatments such as chemotherapy or radiotherapy [2] . This elevation of temperature is obtained by locally submitting the patient to a radio frequency (RF) or microwave electromagnetic field. Rigorously, the calculation of the temperature distribution in the patient during electromagnetic hyperthermia treatment should be performed from the computation of the specific absorption rate (SAR). However, it has been shown that, in a first approximation, the temperature distribution may be directly related to the SAR distribution [3] . The power deposited by an electric field E in a tissue is given by (1) where is the magnitude of the electric field, the electrical conductivity (S/m), and the mass density kg/m of the tissue.
The success of hyperthermia treatment lies in the focalization of the heat inside the cancerous tumor. It is obtained by using several RF sources having specific phases and amplitudes. In this paper, a tool to optimize the SAR distribution in the patient including the specification of constraints is presented. A detailed description of the optimization procedure is first given. Two configurations including the hyperthermia device and a patient are then described. Finally, the optimization procedure is used on these two configurations. 
II. OPTIMIZATION
Energy deposited into the part of the body to be heated is accompanied by energy deposition into other regions. It is impossible to predict intuitively phases and amplitudes of the sources leading to the best focalization. The electric field results from a superposition of fields generated by antennas, which can be controlled separately in amplitude and phase. Optimization of these parameters is consequently required. A genetic algorithm (GA) is then used to optimize the SAR distribution [4] . GA follows the principles of evolution through natural selection to maximize a defined objective function (OF).
A. Electric Field Calculation
To compute the electric field and the SAR distributions, a three-dimensional (3-D) finite element (FE) formulation has been previously developed [5] . The time harmonic formulation is directly written in terms of total electric field (2). It is obtained by applying the Galerkin method to the wave equation. Coupling to a first-order Engquist-Majda absorbing boundary condition (ABC) allows us to take into account the open boundary (2) with , where is the tangential field. Space discretization is performed using incomplete first-order edge elements. Edge elements ensure the continuity of the tangential field components across an interface between different media [6] . Tetrahedral elements are used since they fit on complex geometries such as human tissues or hyperthermia applicators. The resulting sparse complex symmetric matrix equation is solved using conjugate gradient solver with potential projection preconditioning [7] .
The formulation has been validated by comparison to calculated SAR distribution on a phantom to temperature measurements [5] .
B. Optimization Procedure
The hyperthermia system consists of applicators, each of them contributing to a part of the total field. The field distribution due to each source is first computed with the FE method, Several constraints are prescribed for an optimal treatment: the SAR in a tumor has to be close to 50 W/kg, and the total power absorbed by the patient has to be lower than 1250 W [8] . To reach therapeutic temperatures around 42 C, a power density of about 20-40 W/kg at the target region is required [9] . The GA allows us to take into account these two constraints.
C. Objective Functions
Several OFs based on the calculated SAR have been tested and compared [10] . In Table I , , , and are defined as the ratio between the SAR in the tumor and the SAR in healthy tissues. , , and are defined as the ratio between the SAR in the tumor and the SAR in all tissues including healthy tissues and tumor. The GA maximizes the result of these OF in order to obtain maximum SAR in cancerous tissues and the minimun in other tissues. The objective functions , , and implement the coefficient, which allows us to take into account the cooling down of the patient with an external device: is small in the case of a cooled down region and is equal to one in the opposite case. In and , the denominator of the function is replaced by the square of the SAR. In (respectively, ) the denominator of the func- 
III. MODELED DEVICES
Two types of hyperthermia systems are studied. The first one (A1) is made of two waveguides filled with conducting water and radiating at 27.12 MHz (Fig. 1) . The second applicator (A2) is an annular phased array (APA) made of a dielectric ring with eight 110-MHz sources (Fig. 2) . For both devices, a pocket of water (bolus) fills the space around the patient in order to avoid excessive heating at the skin level. The patient model is created from 60 computerized tomography (CT) scans with a slice distance of 10 mm. Table II summarizes the number of elements and degrees of freedom of both configurations.
The electromagnetic and thermal properties of the different biological tissues are presented in Table III. Electromagnetic TABLE II  MODELING OF THE HYPERTHERMIA SYSTEMS   TABLE III  MATERIALS PROPERTIES FOR ALL SEGMENTED TISSUES (INCLUDING THE  TUMOR) USED IN THE PLANNING CALCULATIONS   TABLE IV  OPTIMIZATION RESULTS FOR THE WAVEGUIDES APPLICATOR A1 characteristics are obtained from the Gabriel library [11] and thermal properties (mass flow rate) are given in [12] .
IV. OPTIMIZATION RESULTS
A. Applicator A1
The results of the optimization for applicator A1 are presented in Table IV . Different configurations are compared, with only one source operating (source 1, source 2), with both waveguides operating simultaneously with default adjustments (default values). A and denote, respectively, amplitude and phase of sources. The optimal configurations obtained with the GA for the several OFs are presented. The SAR distribution on bone and tumor is shown in Fig. 3 for default (a) and optimal (b) configurations in the case of function . Fig. 4 gives the ratio between SAR in healthy tissues and in the tumor. 
B. Applicator A2
Results of optimization for applicator A2 are given in Table V . Optimal results obtained with objective function are compared to those obtained with only one source and to those obtained with all sources in phase. Fig. 5 shows the SAR ratio between SAR in healthy tissues and in the tumor for the APA configuration (A2). Computations are performed on an HP station J5000. CPU times for this applicator are given in Table VI . The assembling of the FE matrix is performed only once and is included in the computation of the source 1. Note that the number of iterations of the GA is small, leading to optimization time largely lower than computation time. 
C. Comments
Obviously, the optimization procedure allows us to increase the SAR in the tumor and to decrease it in healthy tissues with several constraints linked to hyperthermia therapeutic levels. It is difficult to get really significant conclusions on the best objective function. With the A1 applicator, maximal value of the power density inside the tumor is obtained with OF4 and OF6. On the other hand, for applicator A2, it is obtained with OF1 and then OF3 and OF6. On the other hand, only the OF5 and OF6 allow us to consider the blood perfusion of the tissues which may have a great role in hypertermia treatment. Furthermore, the OF6 function leads to lower CPU times for the optimization process (Table VII) . From all of these elements, it seems that a good compromise could be the OF6.
V. CONCLUSION
A 3-D optimization tool based on a coupled GA-FE method has been developed for hyperthermia treatment. It allows us to obtain the best settings of sources leading to a better focalization of the SAR into the tumor. The next step of this work is oriented toward the calculation of the temperature distribution resulting from the optimal SAR distribution.
